scholarly journals Genomic Imbalances Are Confined to Non-Proliferating Cells in Paediatric Patients with Acute Myeloid Leukaemia and a Normal or Incomplete Karyotype

PLoS ONE ◽  
2011 ◽  
Vol 6 (6) ◽  
pp. e20607 ◽  
Author(s):  
Erica Ballabio ◽  
Regina Regan ◽  
Elisa Garimberti ◽  
Jochen Harbott ◽  
Jutta Bradtke ◽  
...  
2009 ◽  
Vol 147 (1) ◽  
pp. 125-128 ◽  
Author(s):  
Thomas Lehrnbecher ◽  
Marie-Chantal Ethier ◽  
Theoklis Zaoutis ◽  
Ursula Creutzig ◽  
Alan Gamis ◽  
...  

Author(s):  
Pratik A. Patel ◽  
Stacey A. Lapp ◽  
Gabrielle Grubbs ◽  
Venkata V. Edara ◽  
Christina A. Rostad ◽  
...  

2021 ◽  
Vol 14 (12) ◽  
pp. e247506
Author(s):  
Mohammad Javad Niazmand ◽  
Matthew Speckert ◽  
Donna Johnston

Paediatric patients with acute myeloid leukaemia (AML) often present with symptoms associated with the disruption of normal haematopoiesis and subsequent cellular deficiencies. Periosteal reactions are common in paediatric leukaemia, but typically manifest as a thin, laminated pattern along long bones. Aggressive periosteal reactions are much less frequently seen. Here, we report a case of paediatric AML initially presenting with proptosis and periorbital swelling caused by aggressive, sunburst periosteal reactions surrounding the sphenoid and zygomatic bones. This unique presentation emphasises the importance of considering leukaemic infiltration in the differential for sunburst periosteal reaction in paediatric patients.


2010 ◽  
Vol 63 (11-12) ◽  
pp. 867-869 ◽  
Author(s):  
Natasa Kacanski ◽  
Nada Konstantinidis ◽  
Jovanka Kolarovic ◽  
Bojana Slavkovic ◽  
Dragana Vujic

Introduction. Biphenotypic acute leukaemia is an uncommon type of leukaemia whose blasts co-express myeloid and B-or T-lymphoid antigens. Case report. We describe two cases of paediatric patients with biphenotypic acute leukaemia. A four-year-old female patient was found to have myeloid and B-lymphoid associated antigens in the same blast cells. Cytogenetic analysis showed a Philadelphia (Ph) positivity t (9;22) (q34;q11) with rearrangements of M.bcr-Abl (p210). She was treated with combined acute myeloid leukaemia/acute lymphoblastic leukaemia induction therapy followed by autologous stem cell transplantation. The patient died due to the complications of stem cell transplantation procedure. Another patient was a 20-month-old girl with myeloid and T-lymphoid associated antigens in the blast cells and with normal karyotype. She received acute myeloid leukaemia induction therapy. She has never achieved remission. Discussion. Immunophenotype is essential to establish the diagnosis of biphenotypic acute leukaemia according to the scoring system adopted by the European Group of Immunological Classification of Leukaemia. There is no agreement about uniformity in treatment for the patients with this type of leukaemia. Biphenotypic acute leukaemia is a high risk leukaemia which requires a more intensive treatment. Conclusion. Therapy for every patient with biphenotypic acute leukaemia should depend on their immunophenotype and gene rearrangement profiles.


2019 ◽  
Vol 19 (4) ◽  
pp. 233-234
Author(s):  
Jorrit Schaefer ◽  
Sorcha Cassidy ◽  
Rachel M. Webster

Sign in / Sign up

Export Citation Format

Share Document